Precision lung surgery aims to save healthy tissue while removing cancer

NCT ID NCT07564557

Recruiting now Disease control Sponsor: Shanghai Chest Hospital Source: ClinicalTrials.gov ↗

First seen May 12, 2026 · Last updated May 12, 2026

Summary

This study tests a new surgical technique called septum-guided segmentectomy for people with small (≤2 cm), deep-seated early-stage lung cancer. Instead of removing an entire lung lobe, surgeons use natural lung boundaries to precisely remove only the diseased segment, aiming to preserve more healthy lung function. The trial will follow 89 participants for 3 years to see if the cancer stays away and how well they recover.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shanghai Chest Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200030, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DEEP-SEATED LUNG NODULES EARLY-STAGE LUNG CANCER NON-SMALL CELL LUNG CANCER SOLID-DOMINANT LUNG CANCER